198 related articles for article (PubMed ID: 38722284)
1. Clinical significance of PNO1 as a novel biomarker and therapeutic target of hepatocellular carcinoma.
Roy SK; Srivastava S; McCance C; Shrivastava A; Morvant J; Shankar S; Srivastava RK
J Cell Mol Med; 2024 May; 28(9):e18295. PubMed ID: 38722284
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ribosome assembly factor PNO1 by CRISPR/Cas9 technique suppresses lung adenocarcinoma and Notch pathway: Clinical application.
Roy SK; Srivastava S; Hancock A; Shrivastava A; Morvant J; Shankar S; Srivastava RK
J Cell Mol Med; 2023 Feb; 27(3):365-378. PubMed ID: 36625087
[TBL] [Abstract][Full Text] [Related]
3. Higher expression of SATB2 in hepatocellular carcinoma of African Americans determines more aggressive phenotypes than those of Caucasian Americans.
Yu W; Roy SK; Ma Y; LaVeist TA; Shankar S; Srivastava RK
J Cell Mol Med; 2019 Dec; 23(12):7999-8009. PubMed ID: 31602781
[TBL] [Abstract][Full Text] [Related]
4. EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.
Shen A; Chen Y; Liu L; Huang Y; Chen H; Qi F; Lin J; Shen Z; Wu X; Wu M; Li Q; Qiu L; Yu N; Sferra TJ; Peng J
Cancer Res; 2019 May; 79(9):2257-2270. PubMed ID: 30862720
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte nuclear factor-1beta enhances the stemness of hepatocellular carcinoma cells through activation of the Notch pathway.
Zhu JN; Jiang L; Jiang JH; Yang X; Li XY; Zeng JX; Shi RY; Shi Y; Pan XR; Han ZP; Wei LX
Sci Rep; 2017 Jul; 7(1):4793. PubMed ID: 28684878
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of PRRX1 via the p53-dependent signaling pathway predicts poor prognosis in hepatocellular carcinoma.
Fan M; Shen J; Liu H; Wen Z; Yang J; Yang P; Liu K; Chang Y; Duan J; Lu K
Oncol Rep; 2017 Aug; 38(2):1083-1090. PubMed ID: 28677793
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
8. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
[TBL] [Abstract][Full Text] [Related]
9. PNO1 regulates autophagy and apoptosis of hepatocellular carcinoma via the MAPK signaling pathway.
Han Z; Liu D; Chen L; He Y; Tian X; Qi L; Chen L; Luo Y; Chen Z; Hu X; Li G; Zhan L; Wang Y; Li Q; Chen P; Liu Z; Guo H
Cell Death Dis; 2021 May; 12(6):552. PubMed ID: 34050137
[TBL] [Abstract][Full Text] [Related]
10. Frizzled 2-induced epithelial-mesenchymal transition correlates with vasculogenic mimicry, stemness, and Hippo signaling in hepatocellular carcinoma.
Ou H; Chen Z; Xiang L; Fang Y; Xu Y; Liu Q; Hu Z; Li X; Huang Y; Yang D
Cancer Sci; 2019 Apr; 110(4):1169-1182. PubMed ID: 30677195
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of a novel LncRNA AC104958.2 stabilized by PCBP2 promotes proliferation and microvascular invasion in hepatocellular carcinoma.
Ma Z; Li S; Wang Y; Zhang J; Zeng X
Exp Cell Res; 2021 Oct; 407(1):112791. PubMed ID: 34418457
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib Inhibits Hepatocellular Carcinoma Cell Growth and Migration by Targeting PNO1.
Dai H; Zhang S; Ma R; Pan L
Med Sci Monit; 2019 Sep; 25():7351-7360. PubMed ID: 31568401
[TBL] [Abstract][Full Text] [Related]
13. LINC00261 suppresses cell proliferation, invasion and Notch signaling pathway in hepatocellular carcinoma.
Zhang HF; Li W; Han YD
Cancer Biomark; 2018 Feb; 21(3):575-582. PubMed ID: 29278875
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
[TBL] [Abstract][Full Text] [Related]
16. MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma.
Jin M; Wang J; Ji X; Cao H; Zhu J; Chen Y; Yang J; Zhao Z; Ren T; Xing J
J Exp Clin Cancer Res; 2019 Mar; 38(1):136. PubMed ID: 30909929
[TBL] [Abstract][Full Text] [Related]
17. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
Jin Y; Wang J; Han J; Luo D; Sun Z
Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
[TBL] [Abstract][Full Text] [Related]
18. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
He Y; He X
Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
[TBL] [Abstract][Full Text] [Related]
20. TMEM166 inhibits cell proliferation, migration and invasion in hepatocellular carcinoma via upregulating TP53.
Yang J; Wang B; Xu Q; Yang Y; Hou L; Yin K; Guo Q; Hua Y; Zhang L; Li Y; Zhang J; Li N
Mol Cell Biochem; 2021 Feb; 476(2):1151-1163. PubMed ID: 33200377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
